Millendo Therapeutics, Inc.·4

Feb 4, 4:29 PM ET

Arcudi III Louis J 4

4 · Millendo Therapeutics, Inc. · Filed Feb 4, 2020

Insider Transaction Report

Form 4
Period: 2020-01-31
Arcudi III Louis J
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-01-31+71,25071,250 total
    Exercise: $7.94Exp: 2030-01-30Common Stock (71,250 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on January 7, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION